Nanocrystalline Composites Containing SnO 2 as New Anode Materials for Li-Ion Batteries Principle

S. Indris,A. Ulrich,H. Hahn

Abstract:

What problem does this paper attempt to address?

[The effect of stress on gastrointestinal microflora].

Kh Bernkhardt,M. Knoke

Abstract:
[Influencing Factors of Reproduction Status of Patients Undergoing Laparoscopic Myomectomy].

Guang-hui Song,Song-ying Zhang,Bai-jia Li,Wei,Dong Huang,Xiao-na Lin,Hong-ying Lou

DOI: https://doi.org/10.3760/cma.j.issn.0376-2491.2013.35.014

2013-01-01

Abstract:OBJECTIVE:To explore the influencing factors of reproduction status in women undergoing laparoscopic myomectomy (LM).METHODS:A total of 278 LM patients were recruited.We retrospectively reviewed the reproduction status of 87 pregnant cases after LM. The correlations of their pregnancy outcomes and such clinical profiles as age, operative techniques, biological characteristics of fibroids (number, type, size and location) were analyzed.No uterine rupture occurred during the gestation period.RESULTS:None of them switched to open surgery due to laparoscopic difficulties. However, one patient had a laparoscopic suture for secondary bleeding of uterine incision. At 3 months post-operation, sonography showed no heterogeneous echo, effusion and hematoma in uterine incision.Incision through uterine cavity occurred intraoperatively in 8 cases, but no intrauterine adhesion was found on hysteroscopy 3 months later. And 87 women became pregnant and the postoperative fertilization time was from 2 months to 5 years. Age influenced the postoperative pregnancy rate.Other factors such as location, number and size of fibroid had no impact on fertility.CONCLUSION:For achieving a high conception rate and guaranteeing the safety of pregnant women, a clinician should select reasonable surgical approaches, perform accurate anatomical restoration, apply strict hemostasis and choose a right time of conception.
Comparisons of the efficacy and recurrence of adenomyomectomy for severe uterine diffuse adenomyosis via laparotomy versus laparoscopy: a long-term result in a single institution

Libo Zhu,Shuyi Chen,Xuan Che,Ping Xu,Xiufeng Huang,Xinmei Zhang

DOI: https://doi.org/10.2147/JPR.S205561

2019-06-27

Abstract:Purpose: Studies have shown that adenomyomectomy can effectively treat women with adenomyosis in a short period of time. However, the long-term efficacy of adenomyomectomy has rarely been reported. The objective of this study was to determine whether laparotomy is superior to laparoscopic surgery in the long-term efficacy of double-flap method adenomyomectomy for severe diffuse adenomyosis. Methods: Between March 2011 and September 2018, a total of 148 patients with severe uterine diffuse adenomyosis who underwent laparoscopic (group A, n=72) and laparotomic (group B, n=76) double-flap adenomyomectomy were recruited. Adenomyomectomy efficacy and adenomyosis recurrence after surgery between groups A and B were comparatively analyzed. Results: The effective rate at 6-year follow up after surgery was higher in group B (75.0%) than that in group A (62.1%), while the 6-year cumulative recurrence rate was higher in group A (27.8%) than that in group B (17.1%), but the differences did not reach statistical significance between the two groups (P>0.05). The recurrence rate was lower in patients who were treated with gonadotropin-releasing hormone agonist (GnRHa) plus Mirena or oral contraceptives post-surgically than that in patients who were treated with only GnRHa post-surgically in groups A (51.6% vs 9.8%, P<0.01) and B (33.3% vs 6.5%, P<0.05). Moreover, the recurrence rate of adenomyosis patients with endometriosis was higher than that of adenomyosis patients without endometriosis in group A (55.0% vs 17.3%, P<0.05) and group B (36.0% vs 7.8%, P<0.05). Conclusion: The long-term outcomes of laparoscopic and laparotomic double-flap adenomyomectomy can be achieved for severe diffuse uterine adenomyosis, but laparotomy seems to have advantages over laparoscopy. Postoperative drug use may be beneficial to reduce the recurrence of adenomyosis, especially for adenomyosis with endometriosis.
Efficacy of Laparoscopic Adenomyomectomy Using Double-Flap Method for Diffuse Uterine Adenomyosis

Xiufeng Huang,Qiongshi Huang,Shuyi Chen,Jing Zhang,Kaiqing Lin,Xinmei Zhang

DOI: https://doi.org/10.1186/s12905-015-0182-5

2015-01-01

Abstract:Background Adenomyomectomy has recently been considered the priority option for the treatment of adenomyosis, however, the surgical efficacy and modes are still debated. We aimed to evaluate the efficacy of laparoscopic adenomyomectomy using a double-flap method for the treatment of uterine diffuse adenomyosis when compared with conventional laparoscopic adenomyomectomy. Methods Laparoscopic adenomyomectomy using the conventional method (group A, n = 48) and the double-flap method (group B, n = 46) to treat diffuse uterine adenomyosis, respectively. Visual analog scale (VAS), menstrual amount, serum CA125 levels, and uterine volume were comparatively analyzed in both groups. Results The VAS scores, menstrual amount, serum CA125 levels, and uterine volume at 12 or 24 months after surgery significantly reduced in group B than in group A (P < 0.05); these parameters were statistically decreased in both groups after surgery compared with those obtained before surgery (P < 0.001). Moreover, serum CA125 levels and uterine volume at six months of follow up were significantly lower in group B than in group A (P < 0.01). In addition, blood loss during surgery was similar in groups A and B (P > 0.05), although the operative time was significantly longer in group B than that in group A (P < 0.05). Conclusions Laparoscopic adenomyomectomy using the double-flap method may be an effective technique to treat uterine diffuse adenomyosis.
Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins.

C. J. Chen,D. Clark,K. Ueda,I. Pastan,M. Gottesman,I. Roninson

DOI: https://doi.org/10.1016/s0021-9258(19)40260-3

IF: 5.485

1990-01-05

Journal of Biological Chemistry

Abstract:
Comparative analysis of the clinical efficacy and reproductive outcomes of the hysteroscopic tissue removal system (MyoSure) and hysteroscopic electroresection in the treatment of benign intrauterine lesions

Jiahui Yong,Yajun Wan,Mingzhu Ye,Shuijing Yi,Fei Zeng,Xin Sun,Jiarui Song,Xinyu Wang,Xiangyang Zeng,Songshu Xiao

DOI: https://doi.org/10.1002/ijgo.14863

Abstract:Objective: To compare and analyze the clinical efficacy and reproductive outcomes of the hysteroscopic tissue removal system (MyoSure) and hysteroscopic electroresection in the treatment of benign intrauterine lesions in women of reproductive age. Methods: This is a retrospective study of patients with benign intrauterine lesions treated with MyoSure or hysteroscopic electroresection. The primary outcomes were operative time and resection completeness, and reproductive outcomes were followed up and compared. Secondary outcomes included perioperative adverse events and postoperative adhesions seen during second-look hysteroscopy. Data analysis was performed using χ2 and Fisher tests for qualitative variables and Student t-test for quantitative variables. Results: The operative times of patients with type 0 or I myoma, endometrial polyps, or retained products of conception in the MyoSure group were shorter than those in the electroresection group but were not significantly different for patients with type II myomas. The complete resection rate was lower in the MyoSure group than in the electroresection group. The degree of decrease in the American Fertility Society score of intrauterine adhesion in the MyoSure group was significantly higher (2.90 ± 1.29 points vs 1.31 ± 0.89 points, P = 0.025). The time to pregnancy and the pregnancy rate were higher in the MyoSure group (13.14 ± 7.85 months vs 16.26 ± 8.22 months, P = 0.040; 65.12% vs 54.55%, P = 0.045), but there was no significant difference in the term live birth rate, premature birth rate, or abortion rate between the two groups. Conclusion: MyoSure has advantages of a shortened operative time and improvement in reproductive outcomes such as pregnancy rate. However, for type II myomas, MyoSure has limitations, and a comprehensive evaluation before the procedure is required.
A retrospective multicentre study comparing myomectomy by laparoscopy and laparotomy in current surgical practice. What are the best patient selection criteria?

Henri Marret,Muriel Chevillot,Bruno Giraudeau,Study Group of the French Society of Gynaecology and Obstetrics (Ouest Division)

DOI: https://doi.org/10.1016/j.ejogrb.2004.04.015

2004-11-10

Abstract:Objective: To determine the differences in myoma characteristics before laparoscopic myomectomy (LM) and abdominal myomectomy (AM) and to compare outcomes in current practice. Study design: We analysed retrospectively the data for 126 LMs and 176 AMs performed between January 1996 and January 2000 in 11 centres. Myomas were examined by transvaginal B-mode, colour and pulsed energy Doppler ultrasonography. The following data were collated: (i) pre-operative: myoma size, number, type and location and medical treatment, (ii) per-operative: operator, blood loss, surgical procedure and operative time, and (iii) post-operative: myoma weight and number, haemoglobin decrease, complications and length of hospital stay. Results: Compared to women undergoing LM, women undergoing AM had more myomas that were larger and that were generally interstitial and anterior. More of them received GnRH analogues. Excised myomas weighed four times more, the decrease in haemoglobin was greater (1g/dl), fever was more frequent, and nine patients needed transfusions (compared to none for LM). There were 37 laparoconversions (29%) after LM. The conversion rate was high for inexperienced surgeons. Length of hospital stay was reduced by half for LM (without laparoconversion). Recurrence rate at 2 years was 2.5% for LM versus 3.6% for AM (P = 0.506). Conclusion: Pre-operative evaluation by ultrasound is essential to establish myoma number, size, type and location in order to choose the most appropriate surgical procedure.
The great debate: Surgical outcomes of laparoscopic versus laparotomic myomectomy. A meta-analysis to critically evaluate current evidence and look over the horizon

Andrea Giannini,Ilaria Cuccu,Tullio Golia D'Auge,Emanuele De Angelis,Antonio Simone Laganà,Vito Chiantera,Donatella Caserta,Salvatore Giovanni Vitale,Ludovico Muzii,Ottavia D'Oria,Giorgia Perniola,Giorgio Bogani,Violante Di Donato

DOI: https://doi.org/10.1016/j.ejogrb.2024.03.045

IF: 2.831

2024-04-03

European Journal of Obstetrics & Gynecology and Reproductive Biology

Abstract:Myomectomy is one of the most common surgical procedure in the field of gynecology. However, the role of laparoscopic myomectomy is still debated for many factors, including surgical considerations, safety and fertility concerns, long-term outcomes, and cost-related issues. The aim of this study is to evaluate the surgical peri- and post-operative outcomes of laparoscopic and abdominal myomectomy. A systematic search for studies was performed up to June 2023 through MEDLINE, Pubmed, Embase. Studies reporting the comparison of surgical and obstetrical outcomes in laparoscopic versus laparotomic myomectomy were included for the following outcomes: time of surgery, estimated blood loss, decrease of postoperative hemoglobin, hospital stay, intra-operative complication rates, postoperative complications rates, postoperative analgesic use, postoperative pain at 24 h and pregnancy rate. The meta -analysis was performed using the Cochrane Review software. Fifty-six relevant articles were retrieved through the process of evidence acquisition. Eleven articles met inclusion criteria, for a total of 2,133 patients undergoing laparoscopic or laparotomic myomectomy. The estimated blood loss [standard mean differences (SMD) 0.72, IC 95 % 0.22 to 1.22], the hospital stays [SMD 3.12, IC 95 % 0.57 to 4.28], were significantly lower in laparoscopic than in open group. No statistically significant difference in intra-operative and post-operative complication rates, in pregnancy rate and others obstetrical outcomes between two surgical approaches were found. The findings of present metanalysis suggest that laparoscopic myomectomy offers multiple benefits, including reduced blood loss, shorter hospital stays, and less postoperative analgesic need, without a significant increase in complication rates and similar results in obstetrical outcomes when compared to abdominal myomectomy. However, the presence of few randomized studies on selected population may limit the generalizability of the findings to the entire population. Therefore, more well-designed studies or large population program data to draw definitive conclusions are therefore warranted.

obstetrics & gynecology,reproductive biology
Adenomyosis and fertility‐sparing surgery: A literature appraisal

Giovanni Pecorella,Meletios P. Nigdelis,Radmila Sparic,Andrea Morciano,Andrea Tinelli

DOI: https://doi.org/10.1002/ijgo.15389

2024-01-31

International Journal of Gynecology & Obstetrics

Abstract:Adenomyosis is an intricate pathological condition that negatively impacts the uterus. It is closely related to the more well‐known endometriosis, with which it shares parallels in terms of diagnosis, therapy, and both microscopic and macroscopic features. The purpose of this narrative review is to give a clear univocal definition and outlook on the different, patient‐adapted, surgical treatments. MEDLINE and PubMed searches on these topics were conducted from 1990 to 2022 using a mix of selected keywords. Papers and articles were identified and included in this narrative review after authors' revision and evaluation. From the literature analysis, authors reported the following surgical techniques: laparoscopic double/triple‐flap method, laparotomic wedge resection of the uterine wall, laparotomic transverse H‐incision of the uterine wall, laparotomic wedge‐shaped excision, and laparotomic complete debulking excision by asymmetric dissection technique. Each of these techniques has strengths and weaknesses, but the literature data on the pregnancy rate are somewhat limited. The only certain information is the risk of uterine rupture up to 6.0% after surgical treatment for uterine adenomyosis. Over the years, the surgical approach continued to reach a positive result by minimally invasive treatment, with less hospitalization, less postoperative pain, and less blood loss. Over the years, the gynecological surgeon has gained the skills, training and increasingly sophisticated surgical techniques to target effective therapy. That's why a hysterectomy is no longer the only surgical resource to treat adenomyosis, but in patients who wish to preserve the fertility, there is a wide variety of surgical alternatives.

obstetrics & gynecology
Uterus-sparing operative treatment for adenomyosis

Grigoris F Grimbizis,Themistoklis Mikos,Basil Tarlatzis

DOI: https://doi.org/10.1016/j.fertnstert.2013.10.025

Abstract:Objective: To review systematically the literature on uterus-sparing surgical treatment options for adenomyosis. Design: Systematic literature review. Setting: Tertiary academic center. Patient(s): Women with histologically proven adenomyosis treated with uterus-sparing surgical techniques. Intervention(s): Conservative uterine-sparing surgery for adenomyosis classified as (1) complete excision of adenomyosis, (2) cytoreductive surgery or incomplete removal of the lesion, or (3) nonexcisional techniques, with studies selected if women with adenomyosis were treated surgically without performing hysterectomy. Main outcome measure(s): The cure rate after interventional strategies, the rate of symptom (dysmenorrhea and menorrhagia) control, and pregnancy rate in each group of intervention. Result(s): A quality assessment tool was used to assess the scientific value of each study. In total, 64 studies dealing with 1,049 patients were identified. After complete excision, the dysmenorrhea reduction, menorrhagia control, and pregnancy rate were 82.0%, 68.8%, and 60.5%, respectively. After partial excision, the dysmenorrhea reduction, menorrhagia control, and pregnancy rate were 81.8%, 50.0%, and 46.9%, respectively. Conclusion(s): Uterine-sparing operative treatment of adenomyosis and its variants appear to be feasible and efficacious. Well-designed, comparative studies are urgently needed to answer the multiple questions arising from this intriguing intervention.
Comparison of recurrence rate and risk factors in patients with focal adenomyosis with and without medical treatment after conservative surgery

Wenwen Wang,Xiangyi Ma,Minli Zhang,Zhangying Wu,Tao Xiang,Shixuan Wang

DOI: https://doi.org/10.1002/ijgo.14561

Abstract:Objective: To compare the recurrence rate and risk factors between conservative surgery followed by medical treatments and conservative surgery-only in patients with focal adenomyosis. Methods: This retrospective study was conducted in a single teaching hospital from May 2011 to October 2016. All eligible patients were identified into three groups: surgery-only group, surgery combined with gonadotropin-releasing hormone agonist (GnRHa), and a levonorgestrel-releasing intrauterine system (LNG-IUS) group. The recurrence rate and risk factors were compared among groups using Kaplan-Meier and Cox proportional hazards analyses. Receiver operating characteristic (ROC) curve analysis was applied to determine a cut-off value for identifying recurrence-related risk factors. Results: A total of 249 postoperative patients with adenomyosis were included in the final analysis with a mean of 41 months of follow up. The recurrence rate at the long-term follow up was significantly lower in intervention groups than in the surgery-only group (P = 0.011). The Cox proportional hazards and ROC analyses showed that a menstrual cycle longer than 26 days (P = 0.026), diameter of lesions <6 cm (P = 0.030), and combination treatment using GnRHa (P = 0.039) or LNG-IUS (P = 0.007) were protective against relapse. The risk of recurrence was lower in patients with anterior (P = 0.034) or fundus (P = 0.038) adenomyosis. Conclusion: Postoperative therapy using GnRHa or LNG-IUS decreases the long-term relapse rate in women undergoing conservative surgery.
Effect of different treatment protocols on in vitro fertilisation/intracytoplasmic sperm injection (IVF/ICSI) outcomes in adenomyosis women: a systematic review and meta-analysis

Ge,L.,Li,Y.,Zhou,J.,Zhao,X.,Chen,X.,Wang,W.,Li,Z.,Ge,P.,Cui,L.

DOI: https://doi.org/10.1136/bmjopen-2023-077025

IF: 3.006

2024-07-19

BMJ Open

Abstract:Objectives Pregnancy outcomes of different ovarian stimulation protocols for in vitro fertilisation/intracytoplasmic sperm injection (IVF/ICSI) in patients with adenomyosis are not explicit. This meta-analysis aimed to systematically evaluate the effects of different IVF/ICSI protocols on pregnancy outcomes. Design Meta-analysis. Data sources PubMed, Web of Science and Cochrane library were searched up to October 2023. Eligibility criteria Comparative studies on IVF/ICSI outcomes in the adenomyosis population were eligible. Studies on preimplantation genetic testing, reviews, case reports and animal experiments were excluded. Data extraction and synthesis Valid information was extracted by two independent authors according to a standard data format. All analyses were conducted using Review Manager (RevMan, V.5.3). Results Compared with the non-adenomyosis population, adenomyosis was responsible for a 26% reduction in clinical pregnancy rate (CPR; 42.47% vs 55.89%, OR: 0.74, 95% CI: 0.66 to 0.82, p<0.00001), a 35% reduction in live birth rate (LBR; 30.72% vs 47.77%, OR: 0.65, 95% CI: 0.58 to 0.73, p<0.00001) and a 1.9-fold increase in miscarriage rate (MR; 27.82% vs 13.9%, OR: 1.90, 95% CI: 1.56 to 2.31, p<0.00001). Subgroup analysis suggested that, in fresh embryo transfer (ET) cycles, the CPR (34.4% vs 58.25%) in the long/short/antagonist protocol group was poorer than that in the ultralong protocol group. In frozen ET (FET) cycles, there were no statistical differences in CPR ((GnRHa+FET) AM(adenomyosis) vs non-AM: 51.32% vs 43.48%, p=0.31; (non-GnRHa+FET) AM vs non-AM: 50.25% vs 60.10%, p=0.82), MR ((GnRHa+FET) AM vs non-AM:12.82% vs 12.50%, p=0.97; (non-GnRHa+FET) AM vs non-AM: 30.5% vs 15.54%, p=0.15) and LBR ((GnRHa+FET) AM vs non-AM:44.74% vs 36.96%, p=0.31; (non-GnRHa+FET) AM vs non-AM: 34.42% vs 50.25%, p=0.28). The MR in the adenomyosis group was high in the fresh ET and FET cycles. Conclusions FET might be a better choice for women with adenomyosis, especially those pretreated with GnRHa. In fresh ET cycles, pregnancy outcomes of the long/short/antagonist protocols were poorer than those of the ultralong protocol. Trial registration number CRD42022340743.

medicine, general & internal
The Effect of Uterine Adenomyosis on IVF Outcomes: a Systematic Review and Meta-analysis

Mauro Cozzolino,Silvio Tartaglia,Livia Pellegrini,Gianmarco Troiano,Giuseppe Rizzo,Felice Petraglia

DOI: https://doi.org/10.1007/s43032-021-00818-6

Abstract:To investigate the impact of uterine adenomyosis on in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) clinical outcomes and also to evaluate the impact of gonadotropin-releasing hormone agonist (GnRHa) and surgical treatments. Infertile women with adenomyosis undergoing conventional IVF or ICSI were compared with women without adenomyosis. Fertility outcomes were evaluated in two patients with adenomyosis untreated and treated surgically or medically therapy. The review protocol was registered in PROSPERO (CRD42020214586). We consider the live birth rate (LBR) as the primary outcome. The analysis showed that women with adenomyosis had lower LBR (OR 0.59, 95% CI 0.37-0.92, p = 0.02), clinical pregnancy rate (OR 0.66, 95% CI 0.48-0.90), and ongoing pregnancy rate (OR 0.43, 95% CI 0.21-0.88) compared to those without adenomyosis, and miscarriage rate was higher in women with adenomyosis (OR 2.11, 95% CI 1.33-3.33). Surgical treatment increases natural conception in women with adenomyosis although the paucity of data (only two studies), and conversely, treatment with GnRHa does not increase the IVF outcomes. Women with adenomyosis have decreased IVF clinical outcomes. Pretreatment with the use of long-term GnRHa could not be beneficial, even though only three studies were included in the meta-analysis. The major part of the studies has not divided focal and diffuse adenomyosis, and this represents a relevant source of bias: studies conducted with standardized diagnostic criteria for adenomyosis are still needed to determine if the different clinical presentations of such condition could compromise IVF outcomes.
Prevalence of Intrauterine Adhesions after Myomectomy: A Prospective Multicenter Observational Study

Antonio Simone Laganà,Simone Garzon,Susan Dababou,Stefano Uccella,Mykhailo Medvediev,Darya Pokrovenko,Evgenia Leonidovna Babunashvili,Svetlana Nikolaevna Buyanova,Natalya Alekseevna Schukina,Marina Gennadievna Shcherbatykh Kaschchuk,Ioannis Kosmas,Martina Licchelli,Gaetano Panese,Andrea Tinelli

DOI: https://doi.org/10.1159/000522583

Abstract:Objectives: The aim of this study was to evaluate intrauterine adhesion formation after laparoscopic and laparotomic myomectomy. Design: This is a prospective, multicenter, observational study (ClinicalTrials.gov ID: NCT04030273). Methods: We included patients after laparotomic and laparoscopic myomectomy. All patients underwent postsurgical diagnostic hysteroscopy, after 3 months. The intrauterine adhesion rate and associated factors were investigated. Results: Between January 2020 and December 2020, 38 and 24 consecutive patients underwent laparoscopic and laparotomic myomectomy, respectively. All diagnostic hysteroscopies were performed in the office setting without complications. Intrauterine adhesions were identified in 19.4% of women (95% CI: of 9-29%). Factors univariately associated (p < 0.2) with the presence of intrauterine adhesions after myomectomy were previous uterine surgery, the surgical approach (laparoscopic or laparotomic), the number of removed fibroids, the type and diameter of the largest myoma, and the opening of the uterine cavity. In the multivariable analysis, only the opening of the uterine cavity (odds ratio [OR] 51.99; 95% confidence interval [CI]: 4.53-596.28) and the laparotomic approach (OR, 16.19; 95% CI: 1.66-158.35) were independently associated with the identification of intrauterine adhesions after myomectomy. Limitations: One of the main limitations of our study is that we used uterine manipulator only in the laparoscopic group; in addition, we did not perform a preoperative hysteroscopy to evaluate the rate of intrauterine adhesions potentially present even before the myomectomy. Conclusions: The prevalence of intrauterine adhesions after 3 months from surgery was significantly associated with the opening of the uterine cavity and the laparotomic approach.
The efficacy of medical treatment for adenomyosis after adenomyomectomy

Qiuju Li,Ming Yuan,Ni Li,Qianwei Zhen,Chang Chen,Guoyun Wang

DOI: https://doi.org/10.1111/jog.14376

Abstract:Aims: To compare the efficacy of gonadotropin-releasing hormone agonist (GnRH-a) and GnRH-a + levonorgestrel-releasing intrauterine system (LNG-IUS) after adenomyomectomy for improved adenomyosis-associated symptoms. Methods: Overall, 193 patients with adenomyosis included in this study were categorized into three groups: adenomyomectomy (n = 57, group 1), adenomyomectomy + GnRH-a (n = 83, group 2) and adenomyomectomy + GnRH-a + LNG-IUS (n = 53, group 3). Visual Analog Scale (VAS) scores and uterine volumes were determined to evaluate the severity of adenomyosis. Dysmenorrhea improvement and uterine volume were the main outcomes. Results: The VAS scores of all patients reduced from 7.3 (6.0, 8.5) to 0 (0, 0.6) at the 6 months after surgery, which were significantly higher in group 1 compared to other groups (P < 0.05). In groups 1, 2 and 3, there were 14, 7 and 4 patients, respectively, who suffered dysmenorrhea recurrence. The mean recurrent-free-survival (RFS) was 51.6 ± 2.4, 58.0 ± 1.2 and 58.3 ± 1.0 months, respectively, which was significantly shorter in group 1 (P < 0.05). The dysmenorrhea recurrences were 26.3%, 6.1%, 5.9% in groups 1, 2 and 3, respectively, at the 36 months, which was significantly higher in group 1 (P < 0.01). Significantly decreased uterine volumes were observed in all patients from 222.2 (147.6, 350.4) to 77.0 (65.9, 94.1) mL (P < 0.05) at the 6 month after surgery. Conclusion: Treatment GnRH-a and LNG-IUS after surgery could significantly reduce the recurrence and prolong the RFS. It seemed that the use of LNG-IUS was beneficial for a lower recurrence in long-term follow-up.
A survey of hepatitis C management by Victorian GPs after PBS-listing of direct-acting antiviral therapy.

A. Wade,B. Draper,J. Doyle,N. Allard,P. Grinzi,A. Thompson,M. Hellard

Abstract:BACKGROUND To increase access to hepatitis C virus (HCV) treatment, the Pharmaceutical Benefits Scheme (PBS) enabled general practitioners (GPs) to prescribe direct-acting antiviral (DAA) therapy. We conducted a survey to identify GPs' knowledge and management of HCV. METHODS A questionnaire consisting of 20 items about HCV knowledge and management was sent to 1000 GPs. RESULTS One hundred and ninety-one GPs (19.1%) responded; 74% answered correctly that antibody and RNA positivity is diagnostic of HCV. Only 12% could directly request transient elastography. Although 53% of respondents reported interest in prescribing DAAs, 72% continued to refer all patients to specialists. Fifty-five per cent were unsure if people who currently inject drugs were eligible for treatment. DISCUSSION Most respondents were interested in prescribing DAAs, but education, access to transient elastography and clear consultation pathways are required to translate this interest into increased treatment availability. PBS eligibility of current injectors needs promotion.
Clinical outcome analysis of intramural myoma greater than 8 cm in diameter removed during caesarean section: a retrospective study

Chunbo Shi,Jinliang Chen,Aner Chen

DOI: https://doi.org/10.1186/s12905-023-02210-9

2023-02-11

BMC Women s Health

Abstract:Objective: To explore the safety and efficiency of endometrial myomectomy (EM) and Serosal myomectomy (SM) for the removal of intramural myoma greater than 8 cm in diameter during cesarean section. Methods: Retrospective analysis and follow-up were used, and 190 cases of pregnancy complicated with uterine myoma from Jan. 2017 to May 2022 in Ningbo Women's and Children's Hospital were collected, 130 cases of caesarean myomectomy as study group, 64 cases of EM as study group A, 66 cases of SM as study group B, 33 cases with uterine fibroids removed before suturing the uterine incision as study group B1, 33 cases with uterine incision sutured followed by removal of fibroids as study group B2, 60 cases of Caesarean section alone as control group. To compare perioperative conditions between and within groups. Results: ① Operation time, postoperative exhaust time, pre- and post-operative haemoglobin drop, intraoperative blood loss were all more than those of the control group in the study group (68.65 ± 11.87 vs 56.17 ± 9.18 min, 21.04 ± 4.98 vs 17.03 ± 1.3 h, 1.27 ± 0.59 vs 1.09 ± 0.43 g/dl, 613 ± 221 vs 532 ± 156 ml, P < 0.001, P < 0.001, P = 0.025, P = 0.011). ② For type III and V fibroids, the time of myoma removal, postoperative exhaust and pre- and post-operative haemoglobin drop and intraoperative blood loss in study group A were less than those in study group B (18.02 ± 3.89 vs 20.19 ± 5.32 min, 18.83 ± 2.57 vs 23.93 ± 6.84 h, 600 ± 194 vs 730 ± 277 ml, 1.20 ± 0.57 vs 1.59 ± 0.70 g/dl, P = 0.036, P < 0.001, P = 0.014, P = 0.008); For type IV uterine fibroids, only postoperative exhaust time was less in Study Group A than in Study Group B (19.27 ± 2.2 vs 21.35 ± 3.23 h, P = 0.016). ③ Time of myoma removed was less in study group B1 than in study group B2 (18.24 ± 4.53 vs 20.7 ± 4.59 min, P = 0.033). Conclusion: It is safe and feasible to remove interstitial myomas larger than 8 cm in diameter during caesarean section. EM has the advantage of shorter operation time and less intraoperative bleeding, SM, in a way that the myoma is removed before suturing the uterine incision, can shorten the myomectomy time. It can benefit the patients more.
12872 Endometriosis and Adenomyosis in Women of Reproductive Age With Infertility: From Classification to Reproductive Outcomes

L Adamyan,AA Stepanian,A Sokolov,A Arakelyan,V Bychenko,K Mailova

DOI: https://doi.org/10.1016/j.jmig.2024.09.1020

IF: 4.314

2024-11-22

Journal of Minimally Invasive Gynecology

Abstract:Study Objective Enhancing precision in the management of women with adenomyosis interested fertility by optimizing diagnostic methods, surgical treatment, and intraoperative navigation via newly created 3-dimentional thin-slice uterine model combined with the data of functional MRI and MR-elastography. Design Level II, Canadian Task Force. Setting National Referral Center, Department of Operative Gynecology. Patients or Participants 150 patients of reproductive age with adenomiosis were admitted for surgical treatment and enrolled in cohort study. Groups were divided according to the form of adenomyosis (diffuse, nodular, or cystic). All participants had previous medical treatment, which was ineffective. Interventions Preoperative and intraoperative navigation in laparoscopic uterine reconstruction with utilization of new 3D- model of the adenomyotic uterus combined with the data of functional MRI and MR-elastography in patients with various forms of adenomyosis, interested in uterine preservation and following otherwise standard perioperative protocol. Measurements and Main Results Newly created thin-slice 3-D uterine model allowed for studying of the structural features and anatomical patterns in patients with adenomyosis, including the determination of the exact boundaries of the pathological process, the thickness of the uterine wall, the thickness of the Junctional Zone, density of diffuse and nodular adenomyosis, and circulation; and resulted in the optimization of the surgical tactic, reduction of intraoperative blood loss, reduced intraoperative decision-making time, and duration of surgery. All patients had improved quality of life (reduction of pain syndrome, menstrual blood loss, reproductive outcomes). 40% of patients had combined endometriosis and adenomyosis and 7% had congenital uterine malformations. Conclusion Newly created 3-D uterine model combined with the data obtained with functional MRI and MR-elastography allowed for higher level of precision in preoperative and intraoperative navigation of direction and extent of surgical resection/excision, enhanced by reliable assessment of precise nuances of myometrial circulation and adenomyotic involvement, leading to reliable and safe reconstruction of myometrium in patients with advanced adenomyosis, requiring surgical resection/excision.

obstetrics & gynecology
Intramural Leiomyomas and Fertility: A Systematic Review and Meta-Analysis

Taïna Laurore Pritts,Meghan Ogden,William Parker,Jennifer Ratcliffe,Elizabeth A Pritts

DOI: https://doi.org/10.1097/AOG.0000000000005661

2024-08-01

Abstract:Objective: To evaluate fertility outcomes based on size and number of intramural leiomyomas and outcomes after removal. Data sources: Online searches: MEDLINE, ClinicalTrials.gov , PubMed, Cochrane Library, and PROSPERO Library from 1994 to 2023. Methods of study selection: A total of 5,143 studies were identified, with inclusion of 13 study groups. Tabulation, integration and results: Outcomes for size and number of leiomyomas were reported with clinical pregnancy rates and ongoing pregnancy or live-birth rates. In data sets with maximum leiomyoma diameters of less than 6 cm for study inclusion, women with leiomyomas smaller than 3 cm had lower clinical pregnancy rates than women without leiomyomas, with an odds ratio (OR) of 0.53 (95% CI, 0.38-0.76) and, for ongoing pregnancy or live-birth rates, an OR of 0.59 (95% CI, 0.41-0.86). The ORs for clinical pregnancy rates in women with intermediately-sized leiomyomas (those between 3 cm and 6 cm) were lower than in women without leiomyomas, with an OR at 0.43 (95% CI, 0.29-0.63) and, for ongoing pregnancy or live-birth rates, an OR at 0.38 (95% CI, 0.24-0.59). In data sets without exclusion for women with larger-sized leiomyomas, clinical pregnancy rates were lower for those with leiomyomas smaller than 5 cm compared with those without leiomyomas, with an OR of 0.75 (95% CI, 0.58-0.96). Women with leiomyomas larger than 5 cm showed no differences in clinical pregnancy rate compared with women without leiomyomas, with an OR of 0.71 (95% CI, 0.32-1.58). Although women with a single leiomyoma in any location had no differences in outcomes, those with more than one leiomyoma had lower clinical pregnancy rates and ongoing pregnancy or live-birth rates, with an OR of 0.62 (95% CI, 0.44-0.86) and 0.57 (95% CI, 0.36-0.88), respectively. The clinical pregnancy rate for women undergoing myomectomy for intramural leiomyomas was no different than those with intramural leiomyomas in situ, with an OR of 1.10 (95% CI, 0.77-1.59). Conclusion: Even small intramural leiomyomas are associated with lower fertility; removal does not confer benefit. Women with more than one leiomyoma in any location have reduced fertility.
A South African overview of the virus, vectors, surveillance and unique features of bluetongue.

G. H. Gerdes

Veterinaria italiana

Abstract:The origin of bluetongue (BT) is probably African and the disease was first recognised in South Africa in Merino sheep in the late 18th Century. Diagnostic and research findings for a number of years have been summarised to obtain data relevant to the distribution of BT and its serotypes in the country. The role of ruminant game and cattle as maintenance hosts for BT virus (BTV) is mentioned although cattle appear to have largely replaced antelope in this role. Only about 30% of over 1,000 game animals tested for export were found to be BT-antibody positive. An outbreak of a bluetongue-like disease in cattle is mentioned as are the BT and epizootic haemorrhagic disease of deer (EHD) isolates in the outbreak. A summary by serotype and province of sheep isolates is given and it is pointed out that the sheep population in a province does not reflect the number of isolates made and the province with the largest sheep population has almost the smallest number of BTV isolates and vice-versa. South Africa currently has 21 of the 24 BTV serotypes with 17, 20 and 21 being exotic to the country. The recent retrospective typing of serotype 17 in South Africa is being investigated, as type 17 crosses strongly with type 20, which is absent and also with type 4 which is present. 1, 3, 4 and 2 were the most common serotypes while 18, 19, 22 and 23 were not found among the isolates. Mention is made of BTV isolates made from Culicoides bolitinos catches during two devastating outbreaks of African horse sickness in an unvaccinated population. A six-year Culicoides monitoring project is mentioned and the many BTV isolates made of a variety of serotypes. BTV is endemic in Africa and in South Africa unvaccinated indigenous breeds appear to have achieved a balance with the virus. Indeed, it is possible to find virus, antibody and lesions in asymptomatic animals in different situations. Bluetongue creates a significant trade barrier but the virus remains interesting among a number of other uniquely African viruses.

Nanocrystalline Composites Containing SnO 2 as New Anode Materials for Li-Ion Batteries Principle

[The effect of stress on gastrointestinal microflora].

[Influencing Factors of Reproduction Status of Patients Undergoing Laparoscopic Myomectomy].

Comparisons of the efficacy and recurrence of adenomyomectomy for severe uterine diffuse adenomyosis via laparotomy versus laparoscopy: a long-term result in a single institution

Efficacy of Laparoscopic Adenomyomectomy Using Double-Flap Method for Diffuse Uterine Adenomyosis

Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins.

Comparative analysis of the clinical efficacy and reproductive outcomes of the hysteroscopic tissue removal system (MyoSure) and hysteroscopic electroresection in the treatment of benign intrauterine lesions

A retrospective multicentre study comparing myomectomy by laparoscopy and laparotomy in current surgical practice. What are the best patient selection criteria?

The great debate: Surgical outcomes of laparoscopic versus laparotomic myomectomy. A meta-analysis to critically evaluate current evidence and look over the horizon

Adenomyosis and fertility‐sparing surgery: A literature appraisal

Uterus-sparing operative treatment for adenomyosis

Comparison of recurrence rate and risk factors in patients with focal adenomyosis with and without medical treatment after conservative surgery

Effect of different treatment protocols on in vitro fertilisation/intracytoplasmic sperm injection (IVF/ICSI) outcomes in adenomyosis women: a systematic review and meta-analysis

The Effect of Uterine Adenomyosis on IVF Outcomes: a Systematic Review and Meta-analysis

Prevalence of Intrauterine Adhesions after Myomectomy: A Prospective Multicenter Observational Study

The efficacy of medical treatment for adenomyosis after adenomyomectomy

A survey of hepatitis C management by Victorian GPs after PBS-listing of direct-acting antiviral therapy.

Clinical outcome analysis of intramural myoma greater than 8 cm in diameter removed during caesarean section: a retrospective study

12872 Endometriosis and Adenomyosis in Women of Reproductive Age With Infertility: From Classification to Reproductive Outcomes

Intramural Leiomyomas and Fertility: A Systematic Review and Meta-Analysis

A South African overview of the virus, vectors, surveillance and unique features of bluetongue.